07:07 EST Krystal Biotech (KRYS) sees non-GAAP R&D and SG&A expense $150.0M-$175.0M Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on KRYS: KRYS Earnings this Week: How Will it Perform? Krystal Biotech appoints Saxena as CFO Disclaimer & DisclosureReport an Issue